Dawk70 what a completely nonsensical post.
It closes the wound faster allowing less chance of an opportunistic infection to take hold and lead to amputation .
Medicine is full of treatments which do nothing to treat the underlying cause but are still medically useful and extremely profitable.
Take chrohns and ulcerative colitis for example; JAK inhibitors do nothing to treat tha underlying genetic predisposition for immune system overreaction but still do a good job of treating the symptoms and letting people get on with their lives.
CYP's cells in DFUwill likely have repeat customers as their diabetes is not adequately controlled.
Its a huge market and one which MSB will be unable to compete in due to much higher cost.
Similarly with aGVHD and any otherindications; CYP will eat their lunch. Just a matter of time.
Goodbye and thanks for all the fishes...
- Forums
- ASX - By Stock
- CYP
- Ann: Investor Presentation
CYP
cynata therapeutics limited
Add to My Watchlist
0.00%
!
16.0¢

Ann: Investor Presentation, page-89
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.15M |
Open | High | Low | Value | Volume |
16.0¢ | 16.5¢ | 16.0¢ | $62.06K | 386.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.0¢ | 70000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 0.160 |
3 | 48709 | 0.155 |
5 | 106673 | 0.150 |
2 | 45000 | 0.140 |
1 | 10937 | 0.130 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 70000 | 2 |
0.175 | 77450 | 2 |
0.180 | 146968 | 5 |
0.185 | 35990 | 1 |
0.195 | 19300 | 1 |
Last trade - 14.47pm 25/06/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
SPONSORED BY The Market Online